Radiolabeled Antibody in the Treatment of Primary and Metastatic Liver Malignancies
- 1 January 1986
- book chapter
- Published by Springer Nature
- Vol. 100, 307-314
- https://doi.org/10.1007/978-3-642-82635-1_38
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Distribution of and physiologic factors that affect 131I-antiferritin tumor localization in experimental hepatomaInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Gamma Scintigraphy Using Tc-99m Labeled Antibody to Human Chorionic GonadotropinClinical Nuclear Medicine, 1984
- Selective tumor localization in experimental hepatoma by radiolabeled antiferritin antibodyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Monoclonal antibodies: Potential role in radiation therapy and oncologyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular CarcinomaNew England Journal of Medicine, 1981
- Dosimetry of 131I-labeled anti-ferritin in hepatoma: A model for radioimmunoglobulin dosimetryInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Phase I–II study of radiolabeled antibody integrated in the treatment of primary hepatic malignanciesInternational Journal of Radiation Oncology*Biology*Physics, 1980
- ORAL-CONTRACEPTIVE-ASSOCIATED LIVER TUMOURS: OCCURRENCE OF MALIGNANCY AND DIFFICULTIES IN DIAGNOSISThe Lancet, 1980
- Combined modality therapy of hepatic metastasisCancer, 1979
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978